corilagin has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourgault, S; Gaudreault, R; Haddad, M; Mousseau, N; Nguyen, PT; Ramassamy, C; Sasseville, G; Van De Ven, T; Wiebe, H | 1 |
| Dharmashekara, C; Flores-Holgúın, N; Frau, J; Glossman-Mitnik, D; Jain, A; Kollur, SP; Mandal, SP; Ortega-Castro, J; Patil, SM; Patil, SS; Pradeep, S; Ramu, R; Reddy, P; Shirahatti, PS; Shivamallu, C; Srinivasa, C | 1 |
| Chen, RH; Coghi, P; Guo, X; Hamdoun, S; Law, BYK; Ng, JPL; Wong, VKW; Xia, C; Yang, LJ; Zhang, DW | 1 |
3 other study(ies) available for corilagin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Molecular Interactions of Tannic Acid with Proteins Associated with SARS-CoV-2 Infectivity.
Topics: Algorithms; Angiotensin-Converting Enzyme 2; Coronavirus 3C Proteases; COVID-19; Glucosides; Humans; Hydrolyzable Tannins; Kinetics; Molecular Docking Simulation; Pandemics; Protein Binding; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Surface Plasmon Resonance; Tannins; Virus Internalization | 2022 |
Molecular insights into the
Topics: COVID-19; Molecular Docking Simulation; Molecular Dynamics Simulation; Protease Inhibitors; SARS-CoV-2; Terminalia | 2023 |
Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding.
Topics: Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents; COVID-19; Epstein-Barr Virus Infections; Glucosides; HEK293 Cells; Host-Pathogen Interactions; Humans; Hydrolyzable Tannins; Lentivirus Infections; Male; Maximum Tolerated Dose; Mice, Inbred C57BL; Molecular Docking Simulation; Spike Glycoprotein, Coronavirus | 2021 |